| Issue |
Section |
Title |
File |
| Vol 6, No 1 (2010) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
POSSIBILITIES OF USING RADIODIAGNOSTIC METHODS IN THE STAGING OF URINARY BLADDER CANCER AND IN THE DETERMINATION OF ITS TREATMENT POLICY |
(Rus)
|
| Vol 10, No 1 (2014) |
REVIEW |
INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 10, No 1 (2014) |
CLINICAL CASE |
THE ATYPICAL SITE OF URETERAL METASTASIS IN A PATIENT WITH CASTRATION-REFRACTORY PROSTATE CANCER. A CLINICAL CASE AND A REVIEW OF LITERATURE |
(Rus)
|
| Vol 10, No 2 (2014) |
PROSTATE CANCER |
SURGICAL TREATMENT OF PATIENTS WITH PROSTATE CANCER AT HIGH RISK OF PROGRESSION |
(Rus)
|
| Vol 8, No 1 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
THE SPECIFIC FEATURES OF A RESPONSE TO A TYROSINE KINASE INHIBITOR AGAINST DIFFERENT HISTOLOGICAL TYPES OF KIDNEY CANCER (A REVIEW) |
(Rus)
|
| Vol 9, No 2 (2013) |
CLINICAL CASE |
DIAGNOSIS AND TREATMENT OF METACHRONOUS TESTICULAR CANCER: A CLINICAL CASE |
(Rus)
|
| Vol 7, No 1 (2011) |
PROSTATE CANCER |
EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 9, No 3 (2013) |
LECTURE |
VARIANTS OF THE INFERIOR VENA CAVA AND ITS TRIBUTARIES: THE CLASSIFICATION, EMBRYOGENESIS, CT IMAGING AND CLINICAL SIGNIFICANCE IN PARA-AORTIC LYMPHADENECTOMY |
(Rus)
|
| Vol 9, No 3 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
USE OF A COMBINATION OF АVASTIN AND LOW-DOSE INTERFERON- α IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL-CELL CANCER |
(Rus)
|
| Vol 7, No 2 (2011) |
PROSTATE CANCER |
A ROLE OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER |
(Rus)
|
| Vol 5, No 1 (2009) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
CAUSES OF RADIATION CYSTITIS IN PATIENTS AFTER RADIOTHERAPY FOR SMALL PELVIC MALIGNANCIES |
(Rus)
|
| Vol 9, No 1 (2013) |
CLINICAL CASE |
RENAL ANGIOMYOLIPOMA (A CASE REPORT) |
(Rus)
|
| Vol 6, No 3 (2010) |
PROSTATE CANCER |
PREDICTION OF COMPLICATIONS DUE TO INTRATISSUE RADIOTHERAPY IN MULTIMODALITY TREATMENT FOR PROSTATE CANCER |
(Rus)
|
| Vol 5, No 4 (2009) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
INFERTILITY AS AN ASPECT OF QUALITY OF LIFE IN CANCER PATIENTS |
(Rus)
|
| Vol 6, No 3 (2010) |
REVIEW |
NEW METHODS FOR PREDICTING THE SENSITIVITY OF RENAL CANCER TO IMMUNOTHERAPY ON THE BASIS OF ANALYSIS OF MOLECULAR GENETIC CHARACTERISTICS OF A TUMOR |
(Rus)
|
| Vol 8, No 2 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
IMPROVING THE DIAGNOSIS AND TREATMENT OF RETENTION DISORDERS OF THE UPPER URINARY TRACT IN PATIENTS WITH STAGES IIB–III CANCER OF THE CERVIX UTERI |
(Rus)
|
| Vol 10, No 3 (2014) |
REVIEW |
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer |
(Rus)
|
| Vol 10, No 4 (2014) |
LECTURE |
Molecular diagnosis of prostate cancer: Topical issues |
(Rus)
|
| Vol 10, No 4 (2014) |
PROSTATE CANCER |
Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies |
(Rus)
|
| Vol 11, No 2 (2015) |
PROSTATE CANCER |
Investigation of correlations between different prostate-specific antigen forms and clinical and morphological characteristics of a tumor process in patients with prostate cancer |
(Rus)
|
| Vol 11, No 4 (2015) |
CLINICAL CASE |
Clinical case of patient with ovarian cancer: possibilities of surgical treatment |
(Rus)
|
| Vol 12, No 1 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Ductal prostate cancer |
(Rus)
(Eng)
|
| Vol 12, No 1 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
A system of a unified approach to interpreting prostate magnetic resonance imaging according to the PI-RADSv2 guidelines |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Genetic characteristics of the non-clear cell renal cancer |
(Rus)
(Eng)
|
| Vol 12, No 2 (2016) |
PROSTATE CANCER |
Methods for the diagnosis and treatment of oligometastases in patients with prostate cancer and progressive disease after radical treatment |
(Rus)
(Eng)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
APHIG: a new multiparameter index for prostate cancer |
(Rus)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Salvage lymphadenectomy in patients with lymphogenic prostate cancer progression after radical treatment: results of a multicenter study |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Optimization of sequential targeted therapy |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
PROSTATE CANCER |
Second-line hormonal therapy with the enzalutamid in patients with castrate-resistant prostate cancer |
(Rus)
(Eng)
|
| Vol 13, No 1 (2017) |
PROSTATE CANCER |
Combined chemohormonalradiation treatment of highand very-high-risk non-metastatic prostate cancer |
(Rus)
|
| Vol 13, No 3 (2017) |
CLINICAL CASE |
Neoadjuvant chemohormonal therapy and radical prostatectomy in a patient with lymphogenic metastatic prostate cancer |
(Rus)
|
| Vol 13, No 3 (2017) |
PROSTATE CANCER |
Comparative analysis of the PCA3 gene expression in sediments and exosomes isolated from urine |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Targeted therapy in patients with poor-prognosis renal cell carcinoma |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Prostate cancer brachytherapy. Experience of the branches of the National Medical Research Center of Radiology |
(Rus)
(Eng)
|
| Vol 13, No 4 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Current approaches to selection of the 1st line therapy in patients with metastatic hormone-sensitive prostate cancer |
(Rus)
|
| Vol 14, No 1 (2018) |
REVIEW |
Bladder cancer: what’s new in 2017 |
(Rus)
|
| Vol 14, No 2 (2018) |
REVIEW |
Comparison of the EORTC and CUETO prognostic models in non-muscle-invasive bladder cancer |
(Rus)
|
| Vol 14, No 2 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
NEOADJUVANT AND ADJUVANT CHEMOHORMONAL THERAPY IN PATIENTS WITH HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER: OUR EXPERIENCE |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
BLADDER CANCER: MEDICAL TREATMENT STRATEGIES |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Bladder cancer: what’s new in 2017—2018 |
(Rus)
|
| Vol 14, No 4 (2018) |
REVIEW |
The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer |
(Rus)
|
| Vol 15, No 3 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Polymorphism of μ1-opioid receptor (OPRM1) gene may be of value in genesis of renal malignant neoplasm |
(Rus)
|
| Vol 15, No 2 (2019) |
UROLOGICAL COMPLICATIONS IN CANCER PATIENTS |
Classification of the post radiation fistulas of pelvic organs |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Second line chemotherapy in patients with castration-refractory prostate cancer. Ftom clinical studies to practice |
(Rus)
|
| Vol 15, No 2 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The validation results for APhiGT algorithm for clarification of prostate cancer staging before treatment (first step) |
(Rus)
|
| Vol 15, No 3 (2019) |
REVIEW |
KIM-1 as a potential serological/urinological tumor-associated marker of renal cell carcinoma and chemotherapy nephrotoxicity |
(Rus)
|
| Vol 15, No 2 (2019) |
UROLOGICAL COMPLICATIONS IN CANCER PATIENTS |
Reply to review of the article “Classification of the post r adiation fistulas of pelvic organs” |
(Rus)
|
| Vol 15, No 3 (2019) |
UROLOGICAL COMPLICATIONS IN CANCER PATIENTS |
Approaches for breast cancer treatment in kidney transplant recipient |
(Rus)
|
| Vol 15, No 4 (2019) |
LECTURE |
Basic characteristics and features of the molecular genetic test systems designed for non-invasive diagnostics and prognosis of prostate cancer and bladder cancer |
(Rus)
|
| Vol 15, No 3 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The National Registry of treatment regimens in patients with metastatic castration-resistant prostate cancer in the Russian Federation |
(Rus)
|
| Vol 16, No 1 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The validation of threshold decision ruls and calculator for APhiG algoritm for clarification of prostate cancer staging before treatment |
(Rus)
|
| Vol 15, No 4 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Alpha-therapy using radium-223 chloride in patients with castration-resistant prostate cancer. From clinical researches to routine practice |
(Rus)
|
| Vol 4, No 4 (2008) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Neoadjuvant hormonal therapy with bicalutamide 150 mg before radical treatment in patients with localized and locally advanced prostate cancer |
(Rus)
|
| Vol 3, No 4 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Cost-effectiveness of screening for prostate cancer |
(Rus)
|
| Vol 2, No 4 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Systemic and intravesical ozone therapy for cystitis after radical radiotherapy and complex therapy for small pelvic malignancies |
(Rus)
|
| Vol 2, No 4 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY TRACT TUMORS. CANCER OF THE URETHRA AND PENIS |
Combined organ-preserving therapy for cancer of the penis |
(Rus)
|
| Vol 2, No 1 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Strontium-89 Chloride in Combined Treatment of Hormone Resistant Prostatic Cancer |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients |
(Rus)
|
| Vol 16, No 1 (2020) |
LECTURE |
Radium chloride [223Ra] for patients with prostate cancer and skeletal metastases. Clinical recommendations |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Salvage high-dose-rate brachytherapy for recurrent prostate cancer |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Surgical treatment of patients with high-risk prostate cancer: long-term outcomes and prognostic factors |
(Rus)
|
| Vol 16, No 4 (2020) |
CLINICAL CASE |
Large bladder leiomyoma: a case report |
(Rus)
|
| Vol 16, No 3 (2020) |
REVIEW |
Current opportunities of therapy for patients with non-metastatic castration-resistant prostate cancer |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Comparing the efficacy of laparoscopic and open radical prostatectomy: analysis of treatment outcomes in patients with prostate cancer treated in three federal centers |
(Rus)
|
| Vol 17, No 4 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Combinatorial radiation therapy for prostate cancer with seminal vesicle invasion |
(Rus)
|
| Vol 17, No 4 (2021) |
TOPICAL PROBLEM |
Bosniak classification version 2019: updated algorithms for the diagnosis of cystic renal masses |
(Rus)
|
| Vol 17, No 4 (2021) |
REVIEWS |
Modern possibilities of application 99mTc-labeled prostate-specific membrane antigen ligands in prostate cancer |
(Rus)
|
| Vol 18, No 1 (2022) |
CLINICAL NOTES |
Rare malignant kidney (renal) tumor – leiomyosarcoma of the renal vein (clinical case) |
(Rus)
|
| Vol 18, No 2 (2022) |
REVIEWS |
Prerequisites for lithogenesis after radical cystectomy: literature review |
(Rus)
|
| Vol 18, No 3 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Neoadjuvant chemotherapy and radical cystectomy in patients with bladder cancer |
(Rus)
|
| Vol 19, No 1 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Retroperitoneoscopic access in organ-preserving treatment of renal cell carcinoma |
(Rus)
|
| Vol 19, No 1 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Combined radiotherapy and hormone therapy in unfavorable intermediate risk prostate cancer |
(Rus)
|
| Vol 19, No 2 (2023) |
REVIEWS |
Biomarkers determining treatment tactics in metastatic urothelial cancer |
(Rus)
|
| Vol 19, No 4 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Multiparametric magnetic resonance imaging in diagnosis of local prostate cancer recurrence after radiation therapy and radical prostatectomy: a unified PI-RR reporting system |
(Rus)
|
| Vol 20, No 3 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Comparison of the results of surgical treatment using various types of access in patients with prostate cancer: oncological, functional, and financial effectiveness |
(Rus)
|
| Vol 20, No 2 (2024) |
REVIEWS |
Brachytherapy for organ-preserving treatment of bladder cancer |
(Rus)
|
| Vol 21, No 2 (2025) |
PRECLINICAL STUDIES |
Therapy with a protein-peptide complex from embryonic stem cells as a method of reducing nephrotoxic effect of chemotherapy drug cisplatin |
(Rus)
|
| Vol 21, No 3 (2025) |
REVIEWS |
Personalized approach to systemic treatment of bladder cancer: molecular and genetic markers and new therapeutic strategies (literature review) |
(Rus)
|
